PWA
MYGN icon

Physician Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

Physician Wealth Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7K Sell
1,524
-234
-13% -$1.06K ﹤0.01% 910
2026
Q1 		$7.91K Buy
1,758
+234
+15% +$1.22K ﹤0.01% 867
2025
Q4 		$9.37K Hold
1,524
– – ﹤0.01% 794
2025
Q3 		$11K Hold
1,524
– – ﹤0.01% 732
2025
Q2 		$8.09K Hold
1,524
– – ﹤0.01% 681
2025
Q1 		$13.5K Hold
1,524
– – ﹤0.01% 563
2024
Q4 		$20.9K Buy
+1,524
New +$28.1K ﹤0.01% 498

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Physician Wealth Advisors's MYGN Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Myriad Genetics (MYGN) stake by 13% in Q2 2026, selling an estimated $1.06K and leaving 1,524 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Physician Wealth Advisors first reported a position in MYGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.9K in Q4 2024. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Physician Wealth Advisors held 1,524 shares of Myriad Genetics worth $8.7K as of Q2 2026.
  • Physician Wealth Advisors sold 234 Myriad Genetics shares in Q2 2026, an estimated $1.06K.
  • Myriad Genetics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #910 holding.
  • Physician Wealth Advisors first reported a position in Myriad Genetics in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Myriad Genetics position peaked at $20.9K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.